Kong Fanrong, Gilbert Gwendolyn L
Centre for Infectious Diseases and Microbiology (CIDM), Institute of Clinical Pathology and Medical Research (ICPMR), Westmead, New South Wales, Australia.
Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1815-1821. doi: 10.1099/ijs.0.63073-0.
In 2000, the full genome sequence of Ureaplasma parvum (previously known as Ureaplasma urealyticum) serovar 3 was released. In 2002, after prolonged debate, it was agreed that the former U. urealyticum should be divided into two species -- U. parvum and U. urealyticum. To provide additional support for this decision and improve our understanding of the relationship between these two species, the authors studied four 'core' genes or gene clusters in ATCC reference strains of all 14 serovars of U. parvum and U. urealyticum. These 'core' regions were the rRNA gene clusters, the EF-Tu genes (tuf), urease gene clusters and multiple-banded antigen genes (mba). The known U. parvum genome sequences (GenBank accession no. NC_002162) were used as reference. DNA insertions and deletions (indels) were found in all of the gene regions studied, except tuf, but they were found only between, not within, the two species. An incidental finding was that there was inter-copy heterogeneity for rRNA gene cluster sequences. Sequence analysis (sequence heterogeneity and especially indels) of all four selected targets consistently supported the separation of human ureaplasmas into two species. Except for multiple-banded antigen, there was less heterogeneity in amino acid sequences of proteins, between species, than in the nucleic acid sequences of the corresponding genes. The degrees of heterogeneity at the 5' end of the species-specific regions of multiple-banded antigen were almost identical for both amino acid and nucleotide sequences. Analysis of the authors' results provided an interesting case study to help resolve some common problems in the use of sequence data to infer phylogenetic relationships and support taxonomic changes. It is recommended that, to avoid confusion, the new nomenclature be used for human ureaplasmas in future publications.
2000年,微小脲原体(以前称为解脲脲原体)血清型3的全基因组序列被公布。2002年,经过长时间的争论,人们达成共识,即以前的解脲脲原体应分为两个种——微小脲原体和解脲脲原体。为了给这一决定提供更多支持并增进我们对这两个种之间关系的理解,作者研究了微小脲原体和解脲脲原体所有14个血清型的ATCC参考菌株中的四个“核心”基因或基因簇。这些“核心”区域是rRNA基因簇、EF-Tu基因(tuf)、脲酶基因簇和多带抗原基因(mba)。已知的微小脲原体基因组序列(GenBank登录号NC_002162)用作参考。在所研究的所有基因区域中,除了tuf基因外,均发现了DNA插入和缺失(indels),但它们仅存在于两个种之间,而非种内。一个偶然的发现是rRNA基因簇序列存在拷贝间异质性。对所有四个选定靶点的序列分析(序列异质性,尤其是indels)一致支持将人型脲原体分为两个种。除多带抗原外,种间蛋白质氨基酸序列的异质性低于相应基因的核酸序列。多带抗原种特异性区域5'端的氨基酸和核苷酸序列异质性程度几乎相同。对作者研究结果的分析提供了一个有趣的案例研究,有助于解决在使用序列数据推断系统发育关系和支持分类学变化时的一些常见问题。建议为避免混淆,在未来的出版物中对人型脲原体使用新的命名法。